N-(2,2,2-trifluoroethyl)piperidine-4-carboxamide hydrochloride, 95.0%, 500mg

(2E)-1-(4-ethylphenyl)-3-(furan-2-yl)prop-2-en-1-one, 95.0%, 10g

(3R,4R)-tert-Butyl 4-amino-3-fluoropiperidine-1-carboxylate, 95.0%, 250mg

2-[4-(3,4-dichlorobenzenesulfonamido)phenyl]acetic acid, 97%, 100mg

1,4-Cyclohexadiene ~0.1% hydroquinone as stabilizer, 5g

(6-Bromobenzo[d][1,3]dioxol-5-yl)methanol, 95.0%, 1g

4-(Trifluoromethyl)-1H-pyrrole-2-carboxylic acid, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(pyridin-3-yl)phenyl)propanoic acid, 97%, 250mg

Silybin, ROTICHROM® dCHR, 100 mg, envase de vidrio

3-((3-chloro-4-fluorophenyl)sulfonamido)propanoic acid, 95.0%, 500mg

(8-methoxy-2-methyl-5-quinolinyl)boronic acid dihydrate, 95.0%, 1g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methyl-3-phenylpropanoic acid, 95%, 100mg

ethyl 4-bromo-5-methyl-1H-pyrrole-2-carboxylate, 95.0%, 5g